Takeda Pharmaceutical Company Limited Share Of Other Comprehensive Income Of Associates And Joint Ventures Accounted For Using Equity Method
Takeda Pharmaceutical Company Limited (TKPHF) reported Share Of Other Comprehensive Income Of Associates And Joint Ventures Accounted For Using Equity Method of -JPY 145.00 million for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Income Statement › Other Income
ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod · last filed 2025-06-25
| Period end | Share Of Other Comprehensive Income Of Associates And Joint Ventures Accounted For Using Equity Method 12 month |
|---|---|
| 2025-03-31 | -145.00M JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | -1.79B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | -892.00M JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | -497.00M JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | -299.00M JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | -181.00M JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | -94.00M JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 382.00M JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | -38.00M JPY 20-F · filed 2019-06-27 |